EP. 2: Introduction to IgA Nephropathy
March 31st 2025Panelists discuss how immunoglobulin A (IgA) nephropathy represents a complex glomerular disease characterized by IgA deposition in the mesangium, with a wide spectrum of clinical presentations ranging from benign hematuria to progressive kidney failure requiring comprehensive management strategies.
Watch
EP. 5: Signs and Symptoms of IgA Nephropathy
April 14th 2025Panelists discuss how patients with immunoglobulin A (IgA) nephropathy typically present with microscopic or gross hematuria, often during upper respiratory infections, along with variable proteinuria and sometimes hypertension or decreased kidney function.
Watch
EP. 6: Challenges in Timely Identification of IgA Nephropathy
April 14th 2025Panelists discuss how diagnostic challenges in immunoglobulin A (IgA) nephropathy lead to delayed identification, missed treatment windows, and increased risk of irreversible kidney damage due to the requirement for invasive biopsy, nonspecific symptoms, and variable disease presentation.
Watch
EP. 7: Clinical Impact of IgA Nephropathy and Quality of Life
April 21st 2025Panelists discuss how immunoglobulin A (IgA) nephropathy significantly impacts patients’ quality of life through chronic symptoms, treatment burden, psychological effects, and the looming threat of progressive kidney function decline.
Watch
EP. 8: Overview of Treatment Landscape for IgA Nephropathy: Standard of Care and KDIGO Guidelines
April 21st 2025Panelists discuss how immunoglobulin A (IgA) nephropathy treatment has evolved to include supportive care with optimized blood pressure control and renin-angiotensin system blockade as first-line therapy, with increasingly targeted immunomodulatory approaches for higher-risk patients showing persistent proteinuria.
Watch